Archives for May 2007
Bruce Kehr, CEO of Rockville, MD-based InforMedix, thinks private placement funding is worth the wait. The neuropsychiatrist turned CEO recently explained to the Washington Business Journal his company’s strategy of sticking with private placements over […]
14 May 2007 |
Blog |
The two founders of BlueSky Medical Group, a private med tech company based in Carlsbad, CA, stand to make up to $110 million off a deal with Smith & Nephew. The British giant announced today that it […]
11 May 2007 |
Blog |
Schwarz Pharma today received FDA approval for Neupro, its transdermal patch for treatment of early-stage Parkinson’s disease. Neupro has been on the market in Europe since March 2006 and was approved there for all stages […]
10 May 2007 |
Blog |
Yesterday, according to Red Herring, was “a banner day for life sciences companies searching for money,” with companies from the U.S., Canada, Germany and India announcing funding.
Asmacure, of Quebec City, announced a Series A financing of […]
10 May 2007 |
Blog |
Cash-strapped Acorn Cardiovascular sees light at the end of the tunnel. As reported by the Star Tribune, the St. Paul, MN, company has come to an agreement with FDA to conduct a second, smaller scale […]
9 May 2007 |
Blog, Member Spotlight |
Generic Medical Devices, of Gig Harbor, WA, today received its second 501(k) clearance, for its GMD Universal Surgical Mesh product. The company is the first in the medical device field to implement a generic model […]
9 May 2007 |
Blog |
Device manufacturers should start cozying up to developers of coatings materials, says a new report by Greystone Associates, a medical technology consulting firm based in Amherst, NH. The report, Medical Coatings: Markets and Opportunities, says […]
8 May 2007 |
Blog |
Birmingham, AL-based Brookwood Pharmaceuticals and Targeted Technology Ventures of San Antonio, TX, are teaming up to create a new drug-eluting stent, reports Birmingham Business Journal. The two companies will do so under a newly formed […]
8 May 2007 |
Blog |
Eric Fetters is an experienced business writer who has been covering the medical device and biotechnology industries for over five years. He currently works on staff as a reporter for The Herald, the paper of […]
8 May 2007 |
Blog, Q&A |
An article published today by Nanowerk says that today’s hefty investments in nanotechnology come with risk.
Nanotech applied to diagnostics has raised hopes that diagnosis will eventually be possible at the cellular and sub-cellular levels. The […]
7 May 2007 |
Blog |
